Fifteen-year-old Ella Velez’s favorite gymnastics event is vault. The vault is quick, and she doesn’t have to think very much about what she’s doing unlike other, slower events like the balance beam. But for the past couple of years, Velez has had to be focused on regulating her blood sugar every time she performs gymnastics. But a longtime endocrinologist based in Columbus, Dr. Steven Leichter, helped Piedmont Columbus Regional Midtown become one of the first medical facilities in the country to administer a new treatment designed to delay the onset of Type 1 diabetes.
Clinical trials of MDMA have been promising, but concerns have emerged about the quality of the research. A June hearing scheduled by the Food and Drug Administration is likely to address them.
It can be easy to get your hopes up about exciting new research or alternative approaches to cancer treatment. Here's an insider's guide for figuring out which ones are worth your time.
In a large study, the experimental Alzheimer's drug lecanemab reduced the rate of cognitive decline by 27 percent in people in the early stages of the disease.
The clinics have popped up all over the country, but doctors still don't know the best way to treat these patients, whose symptoms can vary dramatically.
Researchers are trying to learn more about COVID-19 vaccines from original study participants. The quest is hampered because many people who first received a placebo shot are opting for the vaccine.
More than 1 million adult Georgians have had at least one dose of a coronavirus vaccine made either by Pfizer or Moderna. But the vaccines haven’t yet been tested on kids. Now parents can decide whether to enroll their adolescent children in clinical trials of COVID-19 vaccines. GPB’s Ellen Eldridge reports.
Merck, which previously made an Ebola vaccine, had been seen as a serious contender in the worldwide race to come up with an answer to the coronavirus.
